The Case for Simulating Pregnancy By Jessica Allerton June 2, 2026 The Medicine Maker Share Summary Takeaways Insight Report Quiz Poll Top Institutions Top Thought Leaders 1 Karen Yeo emphasizes the importance of pharmacokinetic modeling in addressing drug use gaps during pregnancy. 2 Pregnant women are often excluded from clinical trials, leading to limited data for informed treatment decisions. 3 Physiological changes during pregnancy significantly affect drug metabolism, necessitating tailored dosing guidelines. 4 Physiologically based pharmacokinetic modeling can identify data gaps and foster collaboration for better drug research. 5 Improving communication and evidence availability is crucial for encouraging pregnant women to participate in clinical research.
